Analystreport

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Piper Sandler from $45.00 to $35.00. They now have an "overweight" rating o

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com